Data / Form D filings / Celestia Diagnostics Inc.
Celestia Diagnostics Inc.: Form D filing
Celestia Diagnostics Inc., a biotechnology company in Birmingham, AL, filed a Form D with the SEC in 2025. The latest, on October 16, 2025, reports an offering of $1.5 million with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2000 9TH AVE S, RM F404, Birmingham, AL, 35205
- Phone
- (205) 779-1953
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2091561
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 16, 2025 | New notice | $1,500,000 | $0 | $1,500,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Menachem Mendel Fishman | Executive Officer |
Other biotechnology companies in Alabama that filed recently
- Khaya Biosciences, Inc. $200,000 · Aug 13, 2026
Every Form D from the week of Oct 13, 2025 · All recent filings in Alabama · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Celestia Diagnostics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.